FDA Guidance for Industry: Bioavailability and Bioequivalence Studies for orally administered drug products - General considerations

Title:
FDA Guidance for Industry: Bioavailability and Bioequivalence Studies for orally administered drug products - General considerations

https://www.gmp-compliance.org/files/guidemgr/ucm154838.pdf

Origin/Publisher:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/

Document Type:
Guidance for Industry
Content:
Bioavailability and Bioequivalence Studies for orally administered drug products - General considerations

Go back